ID: ALA3970946

Max Phase: Preclinical

Molecular Formula: C13H12ClN3O3

Molecular Weight: 293.71

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)/C=C\n1cnc(-c2cc(Cl)cc(OC)c2)n1

Standard InChI:  InChI=1S/C13H12ClN3O3/c1-19-11-6-9(5-10(14)7-11)13-15-8-17(16-13)4-3-12(18)20-2/h3-8H,1-2H3/b4-3-

Standard InChI Key:  CVEBPYHHYUVREW-ARJAWSKDSA-N

Associated Targets(Human)

Exportin-1 375 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 293.71Molecular Weight (Monoisotopic): 293.0567AlogP: 2.25#Rotatable Bonds: 4
Polar Surface Area: 66.24Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.70CX LogP: 2.87CX LogD: 2.87
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.64Np Likeness Score: -0.74

References

1.  (2011)  Nuclear transport modulators and uses thereof, 

Source